Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Generation of Somatropin Positive Samples for Anti-doping
NCT04042428Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of somatropin in growth hormone deficiency (GHD) (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Seric concentration of rhGH. Started Oct 2019; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT04042428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04042428.